✦ LIBER ✦

Chromatin changes on the GSTP1 promoter associated with its inactivation in prostate cancer

✍ Scribed by Steven T. Okino; Deepa Pookot; Shahana Majid; Hong Zhao; Long-Cheng Li; Robert F. Place; Rajvir Dahiya

Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 399 KB
Volume: 46
Category: Article
ISSN: 0899-1987
DOI: 10.1002/mc.20313

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Glutathione‐S‐transferases (GSTs) are metabolic enzymes that help detoxify and eliminate harmful chemicals. In prostate tumors, expression of GST π (encoded by GSTP1) is frequently lost because of promoter hypermethylation. Here we analyze the native GSTP1 promoter in cancerous and noncancerous human prostate cells to identify structural features associated with its cancer‐related transcriptional silencing. We find that in noncancerous prostate cells (RWPE‐1 and PWR‐1E) GSTP1 is constitutively expressed, not methylated, highly accessible, bound by transcription factors and associated with histones with activating modifications (histone H3 methylated at lysine 4 and acetylated histones H3 and H4). In contrast, in cancerous prostate cells (LNCaP) GSTP1 is not expressed, extensively methylated, inaccessible, lacks bound transcription factors and is not associated with histones with activating modifications. We do not detect significant levels of histones with repressive modifications (histone H3 methylated at lysine 9 or 27) on GSTP1 in any cell line indicating that they are not associated with cancer‐related GSTP1 silencing. Treatment of LNCaP cells with 5‐azacytidine restores activating histone modifications on GSTP1 and reactivates transcription. We conclude that, in the process of prostate carcinogenesis, activating histone modifications on GSTP1 are lost and the DNA becomes methylated and inaccessible resulting in transcriptional silencing. © 2007 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Dual action on promoter demethylation an

Dual action on promoter demethylation and chromatin by an isothiocyanate restored GSTP1 silenced in prostate cancer

✍ L. G. Wang; A. Beklemisheva; X. M. Liu; A. C. Ferrari; J. Feng; J. W. Chiao 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 300 KB

## Abstract Prostate carcinoma is characterized by the silencing of π‐class glutathione S‐transferase gene (__GSTP1__), which encodes a detoxifying enzyme. The silencing of __GSTP1__, due to aberrant methylation at the CpG island in the promoter/5′‐UTR, occurs in the vast majority of prostate tumor

Ethnic group-related differences in CpG

✍ Hideki Enokida; Hiroaki Shiina; Shinji Urakami; Mikio Igawa; Tatsuya Ogishima; D 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 451 KB 👁 2 views

## Abstract The incidence and mortality of prostate cancer (PC) is approximately 2‐fold higher among African‐Americans as compared to Caucasians and very low in Asian. We hypothesize that inactivation of __GSTP1__ genes through CpG methylation plays a role in the pathogenesis of PC, and its ability

Developmentally specific effects of the

Developmentally specific effects of the DNA cross-linking agent mitomycin C on phosphoenolpyruvate carboxykinase gene expression in vivo: Correlation with changes in chromatin structure within the promoter region of the gene

✍ Rosemary M. Caron; Joshua W. Hamilton 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 234 KB 👁 1 views

## Previous studies in our laboratory have demonstrated that genotoxic chemical carcinogens have strong preferential effects on expression of certain inducible genes at nonovertly toxic doses in vivo. The effects of the DNA cross-linking agent and chemotherapy drug, mitomycin C (MMC), on expressio